Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Strominger

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Medical Care|June 4, 2026
Consistency of a Dementia Diagnosis Between Systems for Patients Receiving Care Through the VA, Traditional Medicare, and Medicare AdvantageLianlian Lei, Sarah L Krein, Kierstdea Petzold, et al.
Journal of the American Geriatrics Society|April 10, 2021
Trends in antipsychotic prescribing among long-term care residents receiving hospice careLauren B Gerlach, Shekinah Fashaw, Julie Strominger, et al.
Journal of the American Geriatrics Society|March 8, 2021
Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016Lauren B Gerlach, Helen C Kales, Hyungjin Myra Kim, et al.
Journal of General Internal Medicine|May 28, 2021
Benzodiazepine Prescribing from VA and Medicare to Dually Enrolled Older Veterans: A Retrospective Cohort StudyLianlian Lei, Julie Strominger, Ilse R Wiechers, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 21, 2026
Characterizing treatment initiation with central nervous system-active polypharmacy among adults with dementiaDonovan T Maust, Rachel C Davis, Julie Strominger, et al.
Journal of the American Geriatrics Society|November 5, 2024
Clinician contributions to central nervous system-active polypharmacy among older adults with dementia in the United StatesSarah E Vordenberg, Rachel C Davis, Julie Strominger, et al.
Journal of the American Medical Directors Association|May 1, 2023
Federal Nursing Home Policies on Antipsychotics had Similar Impacts by Race and Ethnicity for Residents With DementiaTheresa I Shireman, Shekinah Fashaw-Walters, Tingting Zhang, et al.
JAMA|March 9, 2021
Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the USDonovan T Maust, Julie Strominger, H Myra Kim, et al.
Drugs & Aging|January 20, 2025
An Educational Intervention to Promote Central Nervous System-Active Deprescribing in Dementia: A Pilot StudyNoah M Barnett, Sarah E Vordenberg, H Myra Kim, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Medical Care|June 4, 2026
Consistency of a Dementia Diagnosis Between Systems for Patients Receiving Care Through the VA, Traditional Medicare, and Medicare AdvantageLianlian Lei, Sarah L Krein, Kierstdea Petzold, et al.
Journal of the American Geriatrics Society|April 10, 2021
Trends in antipsychotic prescribing among long-term care residents receiving hospice careLauren B Gerlach, Shekinah Fashaw, Julie Strominger, et al.
Journal of the American Geriatrics Society|March 8, 2021
Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016Lauren B Gerlach, Helen C Kales, Hyungjin Myra Kim, et al.
Journal of General Internal Medicine|May 28, 2021
Benzodiazepine Prescribing from VA and Medicare to Dually Enrolled Older Veterans: A Retrospective Cohort StudyLianlian Lei, Julie Strominger, Ilse R Wiechers, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 21, 2026
Characterizing treatment initiation with central nervous system-active polypharmacy among adults with dementiaDonovan T Maust, Rachel C Davis, Julie Strominger, et al.
Journal of the American Geriatrics Society|November 5, 2024
Clinician contributions to central nervous system-active polypharmacy among older adults with dementia in the United StatesSarah E Vordenberg, Rachel C Davis, Julie Strominger, et al.
Journal of the American Medical Directors Association|May 1, 2023
Federal Nursing Home Policies on Antipsychotics had Similar Impacts by Race and Ethnicity for Residents With DementiaTheresa I Shireman, Shekinah Fashaw-Walters, Tingting Zhang, et al.
JAMA|March 9, 2021
Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the USDonovan T Maust, Julie Strominger, H Myra Kim, et al.
Drugs & Aging|January 20, 2025
An Educational Intervention to Promote Central Nervous System-Active Deprescribing in Dementia: A Pilot StudyNoah M Barnett, Sarah E Vordenberg, H Myra Kim, et al.
Pageof 4